Monday, June 17, 2013 Last update: 9:40 PM
Company Tech News as it Breaks
Allergan, Inc.
Website:
http://www.allergan.comAGN
News articles for Allergan, Inc.:
Wednesday, May 1, 2013
- Allergan Reports First Quarter 2013 Operating ResultsAllergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended March 31, 2013. Allergan also announced that its Board of Directors has declared a first quarter ... read more
Tuesday, April 30, 2013
- Allergan Announces Death of Stephen J. Ryan, M.D.Allergan, Inc., (NYSE: AGN) today announced that Stephen J. Ryan, M.D., a member of the Allergan Board of Directors, died on April 29th, 2013 after a short illness. ... read more
Tuesday, April 16, 2013
- Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for LEVADEX® (dihydroergotamine) New Drug ApplicationAllergan, Inc. (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to its New Drug Application (NDA) for ... read more
Wednesday, April 3, 2013
- Allergan Announces Quarterly Conference CallAllergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board, President and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and ... read more
Friday, March 1, 2013
- Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form MergerAllergan, Inc. (NYSE: AGN) (“Allergan”) today announced the expiration of the tender offer (the “Offer”) initiated by its wholly-owned subsidiary, Groundhog Acquisition, Inc. (“Purchaser”), on January 31, ... read more
Tuesday, January 22, 2013
- Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.Allergan, Inc. (NYSE:AGN) and MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today jointly announced that they have entered into a definitive merger agreement whereby Allergan will acquire 100% of the ... read more
Monday, January 7, 2013
- Allergan Announces Quarterly Conference CallAllergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board, President and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and ... read more